Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Stroke
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Stroke
    Migraine and cardiovascular disease: systematic review and meta-analysis - (BMJ)
    TopAbstracts in Stroke 10/29/2009 - (DGNews)
    Further Evidence Backs Extension of Treatment Window for Stroke to 4.5 Hours - (DGNews)
    C-Reactive Protein May Predict MI and Early Death, But Not Stroke - (DGNews)
    Diagnosis of Cardiovascular Disease Associated With Risk of Subsequent Hip Fracture - (DGNews)

    News archive

     Recent webcasts/CME - Stroke
    • The Evolving Role of Antiplatelet Therapy for Atrial Fibrillation: Highlights From the ACC Scientific Sessions 2009
    • Current Standard of Care for Stroke Prevention in Patients With Atrial Fibrillation (AF)
    • Aneurysm Rupture and Subarachnoid Hemorrhage Cerebral Revascularization: The Role of EC-IC Bypass in the 21st Century
      Stenting for Intracranial Atherosclerosis
      Diffusion-Weighted Imaging: Not All That Glitters Is Gold

      Webcasts/CME archive

       Recent cases - Stroke
        Adult Cor Triatriatum Presenting as Cardioembolic Stroke
        Pure Sensory Stroke Form Compression of Putaminal Hemorrhage: A Case Report
        An Echocardiographic-Confirmed Case of Atrial Myxoma Causing Cerebral Embolic Ischemic Stroke: A Case Report
        Diffusion-Negative MRI in Acute Ischemic Stroke: A Case Report
        F-18-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography for the Diagnosis of Takayasu's Arteritis in Stroke: A Case Report

        Cases archive
          




        my personal edition > stroke > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Nicardipine Helps Restore Cerebral Oxygenation in Hypertensive Crisis Without Deleterious Effects: Presented at ISC

        By Paula Moyer

        ORLANDO, FL -- February 27, 2006 -- Intravenous nicardipine is an effective way of restoring cerebral oxygenation without deleterious effects in patients who have been treated for hypertensive crisis, according to investigators who presented their findings here February 17th at the 31st International Stroke Conference (ISC).

        "There was no reduction in oxygen delivery to the brain despite a reduction in the required fraction of inspired oxygen [FiO2] and cerebral perfusion pressure [CPP]," said principal investigator Pradeep K. Narotam, MD. "In ischemic patients, an 81% improvement in cerebral oxygenation was reported." Dr. Narotam is an assistant professor of neurosurgery at Creighton University Medical Center in Omaha, Nebraska.

        The investigators were concerned about the effect of treatment-induced sudden hypotension on cerebral oxygenation in patients who present in acute hypertension and the poor neurologic outcome associated with cerebral oxygen deficiency. They were interested in whether intravenous nicardipine would be neuroprotective because physicians are already using it to reverse vasospasm in such patients.

        Therefore, they designed a single-arm, prospective study to evaluate the effects of nicardipine on patients in acute hypertension who were undergoing brain tissue oxygen monitoring. The investigators recruited 30 patients who had 62 hypertensive episodes. In addition to FiO2 and CPP, they also assessed blood pressure, brain tissue oxygen (PbtO2) intracranial pressure (ICP), central venous pressure (CVP), and mean arterial pressure (MAP). The investigators assessed these parameters before the nicardipine and 4 and 8 hours after treatment. The investigators defined cerebral hypo-oxygenation as a brain tissue oxygen of less than 20 mmHg. They measured brain tissue oxygen with a parenchymal bolt inserted with a twist drill.

        Treatment with nicardipine was associated with a 19-point reduction in MAP at 4 hours, at which time a 21% reduction in mean CPP was documented. The investigators noted that brain tissue oxygen was 26.7 mmHg pre-infusion and 27.37 at four hours.

        Among these patients, 11 patients who had 13 events had low oxygen delivery. Patients with hypo-oxygenation were more likely to have higher systolic blood pressure (P < .025), MAP (P = .04), and brain tissue oxygenation (P = .000); such patients also required higher FiO2 to support oxygen delivery (P = .02). At 4 and 8 hours, the brain tissue oxygen significantly improved (P = .002 and P = .005, respectively), even though the MAP and CPP had decreased (P = .0000072 and P = .0009, respectively).

        These findings led investigators to conclude that nicardipine is an effective treatment of acute hypertension without a harmful effect on brain tissue oxygenation.


        [Presentation title: Impact of IV Nicardipine on Cerebral Oxygenation in Neurologic Disorders Requiring IV Antihypertensive Therapy. Abstract P313]



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send